Tecan Group AG (0QLN)
Market Closed
29 May, 15:30
155. 40
CHF +2.2
+1.44%
2.48B Market Cap
35.34 P/E Ratio
0.66% Div Yield
6,063 Volume
0 Eps
153.2 CHF
Previous Close Want to track 0QLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
0QLN closed Friday higher at 155.4 CHF, an increase of 1.44% from Thursday's close, completing a monthly increase of 15.03% or 20.3 CHF. Over the past 12 months, 0QLN stock gained 21.5%.
0QLN pays dividends to its shareholders, with the most recent payment made on Apr 21, 2026. The next estimated payment will be in In 10 months on Apr 21, 2027 for a total of 3 CHF.
The last earnings report, released on Mar 10, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Tecan Group AG has completed 1 stock splits, with the recent split occurring on Mar 12, 2009.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on SIX (CHF).
Tecan Group AG (0QLN) FAQ
What is the stock price today?
The current price is 155.40 CHF.
On which exchange is it traded?
Tecan Group AG is listed on LSE.
What is its stock symbol?
The ticker symbol is 0QLN.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.66%.
What is its market cap?
As of today, the market cap is 2.48B.
Has Tecan Group AG ever had a stock split?
Tecan Group AG had 1 splits and the recent split was on Mar 12, 2009.
Tecan Group AG Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Monica Manotas CEO | LSE Exchange | CH0012100191 ISIN |
| CH Country | 3,074 Employees | 17 Apr 2026 Last Dividend | 4 May 2001 Last Split | - IPO Date |
Overview
Tecan Group AG is a prominent provider of laboratory instruments and solutions primarily catering to the pharmaceutical, biotechnology, and in-vitro diagnostic sectors, as well as university research departments and diverse laboratories. Operating through its Life Sciences Business and Partnering Business segments, Tecan has established a significant international presence with operations across Switzerland, various European countries, North America, Asia, and other international markets. Founded in 1980 and headquartered in Männedorf, Switzerland, Tecan Group AG has dedicated itself to advancing the field of laboratory sciences through innovation and comprehensive service offerings.
Products and Services
- Liquid Handling and Automation - Tecan provides advanced solutions for automating complex liquid handling tasks to increase efficiency and precision in laboratories.
- Microplate Readers and Washers - These devices are designed for various assay formats, offering flexibility and reliability in reading and washing microplates for laboratories engaged in research and diagnostic activities.
- Consumables - A wide range of high-quality consumables tailored to work seamlessly with Tecan instruments, ensuring optimal performance and reliable results.
- NGS Reagents - Tecan offers reagents specifically designed for Next Generation Sequencing (NGS), facilitating cutting-edge genomic research and applications.
- Immunoassays and Antibodies - The company provides a comprehensive suite of immunoassays and antibodies that support a wide range of research and diagnostic applications.
- Software - Tecan's software solutions enhance the functionality and usability of its laboratory systems, offering intuitive interfaces and powerful data analysis tools.
- Tecan Labwerx - This automation solution is custom-designed to meet the specific needs of laboratories, combining Tecan’s expertise in lab automation with flexible system design.
- PARAMIT - A contract design and manufacturing service offered by Tecan, aimed at developing bespoke solutions for clients in the life sciences and diagnostics fields.
Contact Information
Address: Seestrasse 103
Phone: 41 44 922 88 88
Website: https://www.tecan.com
